Cargando…
Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287583/ https://www.ncbi.nlm.nih.gov/pubmed/37154992 http://dx.doi.org/10.1007/s40123-023-00722-z |
| _version_ | 1785061905156538368 |
|---|---|
| author | Lee, Jaekyoung Lee, Dong Cheol |
| author_facet | Lee, Jaekyoung Lee, Dong Cheol |
| author_sort | Lee, Jaekyoung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10287583 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-102875832023-06-24 Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease Lee, Jaekyoung Lee, Dong Cheol Ophthalmol Ther Correction Springer Healthcare 2023-05-08 2023-08 /pmc/articles/PMC10287583/ /pubmed/37154992 http://dx.doi.org/10.1007/s40123-023-00722-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Lee, Jaekyoung Lee, Dong Cheol Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title | Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title_full | Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title_fullStr | Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title_full_unstemmed | Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title_short | Correction to: Changes in Clinical Activity, Serum Autoantibody Levels, and Chorioretinal Vessels After Systemic Glucocorticoid Therapy in Thyroid Eye Disease |
| title_sort | correction to: changes in clinical activity, serum autoantibody levels, and chorioretinal vessels after systemic glucocorticoid therapy in thyroid eye disease |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287583/ https://www.ncbi.nlm.nih.gov/pubmed/37154992 http://dx.doi.org/10.1007/s40123-023-00722-z |
| work_keys_str_mv | AT leejaekyoung correctiontochangesinclinicalactivityserumautoantibodylevelsandchorioretinalvesselsaftersystemicglucocorticoidtherapyinthyroideyedisease AT leedongcheol correctiontochangesinclinicalactivityserumautoantibodylevelsandchorioretinalvesselsaftersystemicglucocorticoidtherapyinthyroideyedisease |